Renata Limited Reports Unaudited Consolidated Earnings Results for the Quarter and Year-To-Date Ended December 31, 2016
January 27, 2017
Share
Renata Limited reported unaudited consolidated earnings results for the quarter and year-to-date ended December 31, 2016. For the quarter, the company reported turnover and other income of BDT 4,226,741,000 against BDT 3,848,758,000 a year ago. Net profit before tax was BDT 1,023,314,000 against BDT 593,569,000 a year ago. Net profit after tax was BDT 649,946,000 against BDT 520,024,000 a year ago. Total comprehensive income for the period was BDT 651,722,000 against BDT 526,368,000 a year ago. Basic earnings per share were BDT 10.67 against BDT 8.54 a year ago.
For year-to-date, the company reported turnover and other income of BDT 7,745,567,000 against BDT 7,096,200,000 a year ago. Net profit before tax was BDT 1,868,707,000 against BDT 1,306,268,000 a year ago. Net profit after tax was BDT 1,217,809,000 against BDT 1,045,866,000 a year ago. Total comprehensive income for the period was BDT 1,218,782,000 against BDT 1,052,210,000 a year ago. Basic earnings per share were BDT 20.00 against BDT 17.17 a year ago. Cash flows from operating activities were BDT 2,427,893,000 against BDT 549,441,000 a year ago. Net operating cash flow per share was BDT 39.87 against BDT 9.02 a year ago.
Renata PLC, formerly Renata Limited, is a Bangladesh-based pharmaceutical and animal health company. The Company is engaged in manufacturing, marketing and distribution of pharmaceutical, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. The Company also engages in the business as traders, importers, exporters, commission agents of all kinds of goods and services, including pharmaceutical drugs and medicines. Its offerings include Algin Injection, Algin Syrup, Alphapress Tablet, Androcap Capsule, Becosules Capsule, Bredicon Tablet, Cabolin Tablet, Anorexon Tablet, Aquastar Growout Powder, Avinex Powder, Catophos Injection, Eggshell Tmo Powder, Ectorid Injection, Doxivet Powder, Fevenil Injection, Fluximine Injection, Cardipin Tablet, Cartilage Plus Tablet, and Diadin Injection, among others.